- FY2025 profit for the year dropped 63.6% to RMB 22.7 million, due to downward pricing pressure tied to healthcare insurance payment constraints and industry headwinds.
- FY2025 earnings per share fell to RMB 0.03 from RMB 0.07.
- FY2025 gross profit slid 13.3% to RMB 952 million.
- FY2025 revenue declined 9.5% to RMB 2.64 billion, due to downward pricing pressure and insufficient sales volume growth to offset the pricing decline.
- Management said FY2025 was an adjustment year for the ICL industry, with the company’s downward trend narrowing quarter by quarter and continued improvements heading into FY2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adicon Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260325-12066229), on March 25, 2026, and is solely responsible for the information contained therein.
Comments